Cargando…
A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
RATIONALE: Alport syndrome (AS) is an inherited progressive renal failure, characterized by kidney disease, hearing loss, and eye abnormalities. PATIENT CONCERNS: A 7-year-old male child was admitted for persistent microscopic hematuria and proteinuria. DIAGNOSES: Combined with clinical manifestatio...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615339/ https://www.ncbi.nlm.nih.gov/pubmed/34964757 http://dx.doi.org/10.1097/MD.0000000000027890 |
_version_ | 1784604080533929984 |
---|---|
author | Chen, Ji-Yu Cui, Jing-Jing Yang, Xi-Ran Li, Yan-Fang Zhang, Yan-Hua Chen, Jia-Ni Lin, Jun-Yu Zhao, Bo |
author_facet | Chen, Ji-Yu Cui, Jing-Jing Yang, Xi-Ran Li, Yan-Fang Zhang, Yan-Hua Chen, Jia-Ni Lin, Jun-Yu Zhao, Bo |
author_sort | Chen, Ji-Yu |
collection | PubMed |
description | RATIONALE: Alport syndrome (AS) is an inherited progressive renal failure, characterized by kidney disease, hearing loss, and eye abnormalities. PATIENT CONCERNS: A 7-year-old male child was admitted for persistent microscopic hematuria and proteinuria. DIAGNOSES: Combined with clinical manifestations, laboratory testing, pathological changes of kidney and sequencing results, the patient was diagnosed as AS. INTERVENTIONS: The patient was treated with ACEI and tacrolimus drugs for 2 years, but continued to have hematuria and proteinuria. Thus, a genetic analysis was performed using next-generation sequencing in four affected members from the family. OUTCOMES: The findings revealed triple compound heterozygous mutation of COL4A4: three novel variations, c.1045C>T (p. R349X), c.3505+1G>A (splicing), and c.2165G>A (p. G722D). LESSONS: This study was novel in finding that a triple variant of the COL4A4 gene simultaneously in trans and in cis. The effects of multiple mutation sites and the type of gene mutation in AS were also underlined. |
format | Online Article Text |
id | pubmed-8615339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-86153392021-11-26 A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report Chen, Ji-Yu Cui, Jing-Jing Yang, Xi-Ran Li, Yan-Fang Zhang, Yan-Hua Chen, Jia-Ni Lin, Jun-Yu Zhao, Bo Medicine (Baltimore) 3500 RATIONALE: Alport syndrome (AS) is an inherited progressive renal failure, characterized by kidney disease, hearing loss, and eye abnormalities. PATIENT CONCERNS: A 7-year-old male child was admitted for persistent microscopic hematuria and proteinuria. DIAGNOSES: Combined with clinical manifestations, laboratory testing, pathological changes of kidney and sequencing results, the patient was diagnosed as AS. INTERVENTIONS: The patient was treated with ACEI and tacrolimus drugs for 2 years, but continued to have hematuria and proteinuria. Thus, a genetic analysis was performed using next-generation sequencing in four affected members from the family. OUTCOMES: The findings revealed triple compound heterozygous mutation of COL4A4: three novel variations, c.1045C>T (p. R349X), c.3505+1G>A (splicing), and c.2165G>A (p. G722D). LESSONS: This study was novel in finding that a triple variant of the COL4A4 gene simultaneously in trans and in cis. The effects of multiple mutation sites and the type of gene mutation in AS were also underlined. Lippincott Williams & Wilkins 2021-11-24 /pmc/articles/PMC8615339/ /pubmed/34964757 http://dx.doi.org/10.1097/MD.0000000000027890 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 3500 Chen, Ji-Yu Cui, Jing-Jing Yang, Xi-Ran Li, Yan-Fang Zhang, Yan-Hua Chen, Jia-Ni Lin, Jun-Yu Zhao, Bo A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report |
title | A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report |
title_full | A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report |
title_fullStr | A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report |
title_full_unstemmed | A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report |
title_short | A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report |
title_sort | novel compound heterozygous col4a4 mutation in a chinese family with alport syndrome: a care case report |
topic | 3500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615339/ https://www.ncbi.nlm.nih.gov/pubmed/34964757 http://dx.doi.org/10.1097/MD.0000000000027890 |
work_keys_str_mv | AT chenjiyu anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT cuijingjing anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT yangxiran anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT liyanfang anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT zhangyanhua anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT chenjiani anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT linjunyu anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT zhaobo anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT chenjiyu novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT cuijingjing novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT yangxiran novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT liyanfang novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT zhangyanhua novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT chenjiani novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT linjunyu novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport AT zhaobo novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport |